Global Spine Biologics Industry 2017 Market Research Report

1 Industry Overview 1

1.1 Definition and Specifications of Spine Biologics 1

1.1.1 Definition of Spine Biologics 1

1.1.2 Specifications of Spine Biologics 2

1.2 Classification of Spine Biologics 3

1.2.1 Bone Graft 4

1.2.2 Bone Graft Substitute 4

1.2.3 Platelet Rich Plasma 5

1.2.4 BMAC 5

1.3 Applications of Spine Biologics 6

1.3.1 Anterior Cervical Discectomy and Fusion 7

1.3.2 Posterior Lumbar Interbody Fusion 7

1.4 Industry Chain Structure of Spine Biologics 8

1.5 Industry Overview and Major Regions Status of Spine Biologics 8

1.5.1 Industry Overview of Spine Biologics 8

1.5.2 Global Major Regions Status of Spine Biologics 10

1.6 Industry Policy Analysis of Spine Biologics 10

1.7 Industry News Analysis of Spine Biologics 12

2 Manufacturing Cost Structure Analysis of Spine Biologics 15

2.1 Raw Material Suppliers Analysis of Spine Biologics 15

2.2 Equipment Suppliers Analysis of Spine Biologics 16

2.3 Labor Cost Analysis of Spine Biologics 16

2.4 Other Costs Analysis of Spine Biologics 19

2.5 Manufacturing Cost Structure Analysis of Spine Biologics 20

2.6 Manufacturing Process Analysis of Spine Biologics 21

3 Technical Data and Manufacturing Plants Analysis 22

3.1 Capacity of Global Key Manufacturers in 2015 22

3.2 Key Manufacturing Plants Distribution of Global Key Spine Biologics Manufacturers in 2015 22

3.3 R&D Status and Technology Source of Global Spine Biologics Key Manufacturers in 2015 23

4 Capacity, Production and Revenue Analysis of Spine Biologics by Regions, Types and Manufacturers 24

4.1 Global Capacity, Production and Revenue of Spine Biologics by Regions 2011-2016 24

4.2 Global and Major Regions Capacity, Production, Revenue and Growth Rate of Spine Biologics 2011-2016 27

4.3 Global Production and Revenue of Spine Biologics by Types 2011-2016 33

4.4 Global Capacity, Production and Revenue of Spine Biologics by Manufacturers 2011-2016 36

5 Price, Cost, Gross and Gross Margin Analysis of Spine Biologics by Regions, Types and Manufacturers 43

5.1 Price, Cost, Gross and Gross Margin Analysis of Spine Biologics by Regions 2011-2016 43

5.2 Price, Cost, Gross and Gross Margin Analysis of Spine Biologics by Types 2011-2016 46

5.3 Price, Cost, Gross and Gross Margin Analysis of Spine Biologics by Manufacturers 2011-2016 49

6 Consumption Volume, Consumption Value and Sale Price Analysis of Spine Biologics by Regions, Types and Applications 54

6.1 Global Consumption Volume and Consumption Value of Spine Biologics by Regions 2011-2016 54

6.2 Global and Major Regions Consumption Volume, Consumption Value and Growth Rate of Spine Biologics 2011-2016 57

6.3 Global Consumption Volume and Consumption Value of Spine Biologics by Types 2011-2016 62

6.4 Global Consumption Volume and Consumption Value of Spine Biologics by Applications 2011-2016 65

6.5 Sale Price of Spine Biologics by Regions 2011-2016 68

6.6 Sale Price of Spine Biologics by Types 2011-2016 68

6.7 Sale Price of Spine Biologics by Applications 2011-2016 69

7 Supply, Import, Export and Consumption Analysis of Spine Biologics 70

7.1 Supply, Consumption and Gap of Spine Biologics 2011-2016 70

7.2 Global Capacity, Production, Price, Cost, Revenue, Supply, Import, Export and Consumption of Spine Biologics 2011-2016 71

7.3 North America Capacity, Production, Price, Cost, Revenue, Supply, Import, Export and Consumption of Spine Biologics 2011-2016 72

7.4 Europe Capacity, Production, Price, Cost, Revenue, Supply, Import, Export and Consumption of Spine Biologics 2011-2016 73

7.5 Asia Capacity, Production, Price, Cost, Revenue, Supply, Import, Export and Consumption of Spine Biologics 2011-2016 74

8 Analysis of Spine Biologics Industry Key Manufacturers 75

8.1 Medtronic 75

8.1.1 Company Profile 75

8.1.2 Product Information 76

8.1.3 Capacity, Production, Price, Cost, Gross, and Revenue 76

8.2 Depuy Synthes 78

8.2.1 Company Profile 78

8.2.2 Product Information 80

8.2.3 Capacity, Production, Price, Cost, Gross, and Revenue 80

8.3 Stryker Corporation 82

8.3.1 Company Profile 82

8.3.2 Product Information 83

8.3.3 Capacity, Production, Price, Cost, Gross, and Revenue 83

8.4 Nuvasive 85

8.4.1 Company Profile 85

8.4.2 Product Information 86

8.4.3 Capacity, Production, Price, Cost, Gross, Revenue and Gross Margin 86

8.5 Zimmer Biomet 88

8.5.1 Company Profile 88

8.5.2 Product Information 89

8.5.3 Capacity, Production, Price, Cost, Gross, and Revenue 89

8.6 Orthofix International 91

8.6.1 Company Profile 91

8.6.2 Product Information 92

8.6.3 Capacity, Production, Price, Cost, Gross, Revenue and Gross Margin 92

8.7 Globus Medical 94

8.7.1 Company Profile 94

8.7.2 Product Information 95

8.7.3 Capacity, Production, Price, Cost, Gross, Revenue and Gross Margin 95

8.8 Alphatec spine 97

8.8.1 Company Profile 97

8.8.2 Product Information 98

8.8.3 Capacity, Production, Price, Cost, Gross, Revenue and Gross Margin 98

8.9 K2M 100

8.9.1 Company Profile 100

8.9.2 Product Information 101

8.9.3 Capacity, Production, Price, Cost, Gross, and Revenue 101

8.10 Exactech 103

8.10.1 Company Profile 103

8.10.2 Product Information 104

8.10.3 Capacity, Production, Price, Cost, Gross, and Revenue 104

8.11 Wright Medical Technology 106

8.11.1 Company Profile 106

8.11.2 Product Information 107

8.11.3 Capacity, Production, Price, Cost, Gross, Revenue and Gross Margin 107

8.12 X-Spine Systems 109

8.12.1 Company Profile 109

8.12.2 Product Information 110

8.12.3 Capacity, Production, Price, Cost, Gross, Revenue and Gross Margin 110

8.13 Nutech 112

8.13.1 Company Profile 112

8.13.2 Product Information 113

8.13.3 Capacity, Production, Price, Cost, Gross, and Revenue 113

8.14 Arthrex 115

8.14.1 Company Profile 115

8.14.2 Product Information 116

8.14.3 Capacity, Production, Price, Cost, Gross, and Revenue 116

9 Marketing Trader or Distributor Analysis of Spine Biologics 118

9.1 Marketing Channels Status of Spine Biologics 118

9.2 Traders or Distributors with Contact Information of Spine Biologics 119

9.3 Ex-work Price, Channel Price and End Buyer Price Analysis of Spine Biologics 120

9.4 Regional Import, Export and Trade Analysis of Spine Biologics 120

11 Development Trend of Analysis of Spine Biologics 122

11.1 Capacity, Production and Revenue Forecast of Spine Biologics by Regions and Types 122

11.1.1 Global Capacity, Production and Revenue of Spine Biologics by Regions 2016-2021 122

11.1.2 Global and Major Regions Capacity, Production, Revenue and Growth Rate of Spine Biologics 2016-2021 125

11.1.3 Global Capacity, Production and Revenue of Spine Biologics by Types 2016-2021 130

11.2 Consumption Volume and Consumption Value Forecast of Spine Biologics by Regions, Types and Applications 133

11.2.1 Global Consumption Volume and Consumption Value of Spine Biologics by Regions 2016-2021 133

11.2.2 Global and Major Regions Consumption Volume, Consumption Value and Growth Rate of Spine Biologics 2016-2021 136

11.2.3 Global Consumption Volume and Consumption Value of Spine Biologics by Types 2016-2021 141

11.2.4 Global Consumption Volume and Consumption Value of Spine Biologics by Applications 2016-2021 144

11.3 Supply, Import, Export and Consumption Forecast of Spine Biologics 147

11.3.1 Supply, Consumption and Gap of Spine Biologics 2016-2021 147

11.3.2 Global Capacity, Production, Price, Cost, Revenue, Supply and Consumption of Spine Biologics 2016-2021 148

11.3.3 North America Capacity, Production, Price, Cost, Revenue, Supply and Consumption of Spine Biologics 2016-2021 149

11.3.4 Europe Capacity, Production, Price, Cost, Revenue, Supply and Consumption of Spine Biologics 2016-2021 149

11.3.5 Asia Capacity, Production, Price, Cost, Revenue, Supply and Consumption of Spine Biologics 2016-2021 150

12 New Project Investment Feasibility Analysis of Spine Biologics 151

12.1 New Project SWOT Analysis of Spine Biologics 151

12.2 New Project Investment Feasibility Analysis of Spine Biologics 151

12.2.1 Project Name 151

12.2.2 Investment Budget 151

12.2.3 Project Product Solutions 152

13 Conclusion of the Global Spine Biologics Industry 2016 Market Research Report 153

Figure Picture of Spine Biologics 1

Table Comparison of Main Models from Spine Biologics Major Manufacturers 2

Table Specification of Main Models from Spine Biologics Major Brand 2

Table Specification Comparison of Different Types of Spine Biologics 3

Figure Global Production Market Share of Spine Biologics by Type in 2015 3

Figure Bone Graft Picture 4

Figure Bone Graft Substitute Picture 4

Figure Platelet Rich Plasma Picture 5

Figure BMAC Picture 5

Table Applications of Spine Biologics 6

Figure 2015 Global Spine Biologics Major Applications Sales Share 6

Figure Anterior Cervical Discectomy and Fusion Examples 7

Figure Posterior Lumbar Interbody Fusion Examples 7

Figure Industry Chain Structure of Spine Biologics 8

Table Global Spine Biologics Major Manufacturers 9

Table Global Major Regions Spine Biologics Production Market Share in 2015 10

Table Industry Policy of Spine Biologics 10

Table Industry News List of Spine Biologics 12

Table Raw Material Suppliers Analysis 15

Table Equipment Suppliers Analysis 16

Figure 2014 APAC Overview of Average Monthly Labor Cost 17

Figure 2014 Americas Overview of Average Monthly Labor Cost 17

Figure 2014 EMEA Overview of Average Monthly Labor Cost 18

Figure 2010-2015 USA Employment Cost Index (ECI) 18

Figure 2010-2014 China Average Wage of Worker and Growth Rate (CNYa) 19

Table 2015 Electricity Price of Industry (USDKW·h) by Some Country 19

Table Manufacturing Cost Structure Analysis of Spine Biologics in 2015 20

Figure Manufacturing Process Analysis of Spine Biologics 21

Table Capacity (K Units) of Global Spine Biologics Key Manufacturers in 2015 22

Table Key Manufacturing Plants Distribution of Global Spine Biologics Major Manufacturers in 2015 22

Table R&D Status and Technology Source of Global Spine Biologics Key Manufacturers in 2015 23

Table Global Capacity (K Units) of Spine Biologics by Regions 2011-2016 24

Figure Global Capacity Market Share of Spine Biologics by Regions in 2011 24

Figure Global Capacity Market Share of Spine Biologics by Regions in 2015 25

Table Global Production (K Units) of Spine Biologics by Regions 2011-2016 25

Figure Global Production Market Share of Spine Biologics by Regions in 2011 25

Figure Global Production Market Share of Spine Biologics by Regions in 2015 26

Table Global Revenue (M USD) of Spine Biologics by Regions 2011-2016 26

Figure Global Revenue Market Share of Spine Biologics by Regions in 2011 26

Figure Global Revenue Market Share of Spine Biologics by Regions in 2015 27

Figure Global Capacity (K Units), Production (K Units) and Growth Rate of Spine Biologics 2011-2016 27

Figure Global Capacity Utilization Rate of Spine Biologics 2011-2016 28

Figure Global Revenue (M USD) and Growth Rate of Spine Biologics 2011-2016 28

Figure North America Capacity (K Units), Production (K Units) and Growth Rate of Spine Biologics 2011-2016 29

Figure North America Capacity Utilization Rate of Spine Biologics 2011-2016 29

Figure North America Revenue (M USD) and Growth Rate of Spine Biologics 2011-2016 30

Figure Europe Capacity (K Units), Production (K Units) and Growth Rate of Spine Biologics 2011-2016 30

Figure Europe Capacity Utilization Rate of Spine Biologics 2011-2016 31

Figure Europe Revenue (M USD) and Growth Rate of Spine Biologics 2011-2016 31

Figure Asia Capacity (K Units), Production (K Units) and Growth Rate of Spine Biologics 2011-2016 32

Figure Asia Capacity Utilization Rate of Spine Biologics 2011-2016 32

Figure Asia Revenue (M USD) and Growth Rate of Spine Biologics 2011-2016 33

Table Global Production (K Units) of Spine Biologics by Types 2011-2016 33

Figure Global Production Market Share of Spine Biologics by Types in 2011 34

Figure Global Production Market Share of Spine Biologics by Types in 2015 34

Table Global Revenue (M USD) of Spine Biologics by Types 2011-2016 35

Figure Global Revenue Market Share of Spine Biologics by Types in 2011 35

Figure Global Revenue Market Share of Spine Biologics by Types in 2015 36

Table Global and Major Manufacturers Capacity (K Units) of Spine Biologics 2011-2016 36

Table Global Capacity Market Share of Spine Biologics Major Manufacturers 2011-2016 37

Figure Global Capacity Market Share of Spine Biologics Major Manufacturers in 2011 37

Figure Global Capacity Market Share of Spine Biologics Major Manufacturers in 2015 38

Table Global and Major Manufacturers Production (K Units) of Spine Biologics 2011-2016 38

Table Global Production Market Share of Spine Biologics Major Manufacturers 2011-2016 39

Figure Global Production Market Share of Spine Biologics Major Manufacturers in 2011 39

Figure Global Production Market Share of Spine Biologics Major Manufacturers in 2015 40

Table Global and Major Manufacturers Revenue (M USD) of Spine Biologics 2011-2016 40

Table Global Revenue Market Share of Spine Biologics Major Manufacturers 2011-2016 41

Figure Global Revenue Market Share of Spine Biologics Major Manufacturers in 2011 41

Figure Global Revenue Market Share of Spine Biologics Major Manufacturers in 2015 42

Table Price (USDUnit) of Spine Biologics by Regions 2011-2016 43

Figure Price (USDUnit) of Spine Biologics by Regions in 2015 43

Table Cost (USDUnit) of Spine Biologics by Regions 2011-2016 44

Figure Cost (USDUnit) of Spine Biologics by Regions in 2015 44

Table Gross (USDUnit) of Spine Biologics by Regions 2011-2016 44

Figure Gross (USDUnit) of Spine Biologics by Regions in 2015 45

Table Gross Margin of Spine Biologics by Regions 2011-2016 45

Figure Gross Margin of Spine Biologics by Regions in 2015 45

Table Price (USDUnit) of Spine Biologics by Types 2011-2016 46

Figure Price (USDUnit) of Spine Biologics by Types in 2015 46

Table Cost (USDUnit) of Spine Biologics by Types 2011-2016 46

Figure Cost (USDUnit) of Spine Biologics by Types in 2015 47

Table Gross (USDUnit) of Spine Biologics by Types 2011-2016 47

Figure Gross (USDUnit) of Spine Biologics by Types in 2015 48

Table Gross Margin of Spine Biologics by Types 2011-2016 48

Figure Gross Margin of Spine Biologics by Types in 2015 49

Table Price (USDUnit) of Spine Biologics by Manufacturers 2011-2016 49

Figure Price (USDUnit) of Spine Biologics by Manufacturers in 2015 50

Table Cost (USDUnit) of Spine Biologics by Manufacturers 2011-2016 50

Figure Cost (USDUnit) of Spine Biologics by Manufacturers in 2015 51

Table Gross (USDUnit) of Spine Biologics by Manufacturers 2011-2016 51

Figure Gross (USDUnit) of Spine Biologics by Manufacturers in 2015 52

Table Gross Margin of Spine Biologics by Manufacturers 2011-2016 52

Figure Gross Margin of Spine Biologics by Manufacturers in 2015 53

Table Global Consumption Volume (K Units) of Spine Biologics by Regions 2011-2016 54

Figure Global Consumption Volume Market Share of Spine Biologics by Regions in 2011 55

Figure Global Consumption Volume Market Share of Spine Biologics by Regions in 2015 55

Table Global Consumption Value (M USD) of Spine Biologics by Regions 2011-2016 56

Figure Global Consumption Value Market Share of Spine Biologics by Regions in 2011 56

Figure Global Consumption Value Market Share of Spine Biologics by Regions in 2015 57

Figure Global Consumption Volume (K Units) and Growth Rate of Spine Biologics 2011-2016 57

Figure Global Consumption Value (M USD) and Growth Rate of Spine Biologics 2011-2016 58

Figure North America Consumption Volume (K Units) and Growth Rate of Spine Biologics 2011-2016 58

Figure North America Consumption Value (M USD) and Growth Rate of Spine Biologics 2011-2016 59

Figure Europe Consumption Volume (K Units) and Growth Rate of Spine Biologics 2011-2016 59

Figure Europe Consumption Value (M USD) and Growth Rate of Spine Biologics 2011-2016 60

Figure China Consumption Volume (K Units) and Growth Rate of Spine Biologics 2011-2016 60

Figure China Consumption Value (M USD) and Growth Rate of Spine Biologics 2011-2016 61

Figure Asia (Ex. China) Consumption Volume (K Units) and Growth Rate of Spine Biologics 2011-2016 61

Figure Asia (Ex. China) Consumption Value (M USD) and Growth Rate of Spine Biologics 2011-2016 62

Table Global Consumption Volume (K Units) of Spine Biologics by Types 2011-2016 62

Figure Global Consumption Volume Market Share of Spine Biologics by Types in 2011 63

Figure Global Consumption Volume Market Share of Spine Biologics by Types in 2015 63

Table Global Consumption Value (M USD) of Spine Biologics by Types 2011-2016 64

Figure Global Consumption Value Market Share of Spine Biologics by Types in 2011 64

Figure Global Consumption Value Market Share of Spine Biologics by Types in 2015 65

Table Global Consumption Volume (K Units) of Spine Biologics by Applications 2011-2016 65

Figure Global Consumption Volume Market Share of Spine Biologics by Applications in 2011 66

Figure Global Consumption Volume Market Share of Spine Biologics by Applications in 2015 66

Table Global Consumption Value (M USD) of Spine Biologics by Applications 2011-2016 67

Figure Global Consumption Value Market Share of Spine Biologics by Applications in 2011 67

Figure Global Consumption Value Market Share of Spine Biologics by Applications in 2015 68

Table Sale Price (USDUnit) of Spine Biologics by Regions 2011-2016 68

Table Sale Price (USDUnit) of Spine Biologics by Types 2011-2016 68

Table Sale Price (USDUnit) of Spine Biologics by Applications 2011-2016 69

Table Global Supply, Consumption and Gap of Spine Biologics 2011-2016 (K Units) 70

Table North America Supply, Consumption and Gap of Spine Biologics 2011-2016 (K Units) 70

Table Europe Supply, Consumption and Gap of Spine Biologics 2011-2016 (K Units) 70

Table Asia Supply, Consumption and Gap of Spine Biologics 2011-2016 (K Units) 71

Table Global Capacity (K Units), Production (K Units), Price (USDUnit), Cost (USDUnit), Revenue (M USD) and Gross Margin of Spine Biologics 2011-2016 71

Table North America Capacity (K Units), Production (K Units), Price (USDUnit), Cost (USDUnit), Revenue (M USD) and Gross Margin of Spine Biologics 2011-2016 72

Table North America Supply, Import, Export and Consumption of Spine Biologics 2011-2016 (K Units) 72

Table Europe Capacity (K Units), Production (K Units), Price (USDUnit), Cost (USDUnit), Revenue (M USD) and Gross Margin of Spine Biologics 2011-2016 73

Table Europe Supply, Import, Export and Consumption of Spine Biologics 2011-2016 (K Units) 73

Table Asia Capacity (K Units), Production (K Units), Price (USDUnit), Cost (USDUnit), Revenue (M USD) and Gross Margin of Spine Biologics 2011-2016 74

Table Asia Supply, Import, Export and Consumption of Spine Biologics 2011-2016 (K Units) 74

Table Medtronic Company Profile 75

Figure Spine Biologics Product Picture of Medtronic 76

Table Spine Biologics Capacity (K Units), Production (K Units), Price (USDUnit), Cost (USDUnit), Gross (USDUnit), Revenue (M USD) and Gross Margin of Medtronic 2011-2016 76

Figure Spine Biologics Capacity (K Units), Production (K Units) and Growth Rate of Medtronic 2011-2016 77

Figure Spine Biologics Production (K Units) and Global Market Share of Medtronic 2011-2016 77

Table Depuy Synthes Company Profile 78

Figure Spine Biologics Product Picture of Depuy Synthes 80

Table Spine Biologics Capacity (K Units), Production (K Units), Price (USDUnit), Cost (USDUnit), Gross (USDUnit), Revenue (M USD) and Gross Margin of Depuy Synthes 2011-2016 80

Figure Spine Biologics Capacity (K Units), Production (K Units) and Growth Rate of Depuy Synthes 2011-2016 81

Figure Spine Biologics Production (K Units) and Global Market Share of Depuy Synthes 2011-2016 81

Table Stryker Corporation Company Profile 82

Figure Spine Biologics Product Picture of Stryker Corporation 83

Table Spine Biologics Capacity (K Units), Production (K Units), Price (USDUnit), Cost (USDUnit), Gross (USDUnit), Revenue (M USD) and Gross Margin of Stryker Corporation 2011-2016 83

Figure Spine Biologics Capacity (K Units), Production (K Units) and Growth Rate of Stryker Corporation 2011-2016 84

Figure Spine Biologics Production (K Units) and Global Market Share of Stryker Corporation 2011-2016 84

Table Nuvasive Company Profile 85

Figure Spine Biologics Product Picture of Nuvasive 86

Table Spine Biologics Capacity (K Units), Production (K Units), Price (USDUnit), Cost (USDUnit), Gross (USDUnit), Revenue (M USD) and Gross Margin of Nuvasive 2011-2016 86

Figure Spine Biologics Capacity (K Units), Production (K Units) and Growth Rate of Nuvasive 2011-2016 87

Figure Spine Biologics Production (K Units) and Global Market Share of Nuvasive 2011-2016 87

Table Zimmer Biomet Company Profile 88

Figure Spine Biologics Product Picture of Zimmer Biomet 89

Table Spine Biologics Capacity (K Units), Production (K Units), Price (USDUnit), Cost (USDUnit), Gross (USDUnit), Revenue (M USD) and Gross Margin of Zimmer Biomet 2011-2016 89

Figure Spine Biologics Capacity (K Units), Production (K Units) and Growth Rate of Zimmer Biomet 2011-2016 90

Figure Spine Biologics Production (K Units) and Global Market Share of Zimmer Biomet 2011-2016 90

Table Orthofix International Company Profile 91

Figure Spine Biologics Product Picture of Orthofix International 92

Table Spine Biologics Capacity (K Units), Production (K Units), Price (USDUnit), Cost (USDUnit), Gross (USDUnit), Revenue (M USD) and Gross Margin of Orthofix International 2011-2016 92

Figure Spine Biologics Capacity (K Units), Production (K Units) and Growth Rate of Orthofix International 2011-2016 93

Figure Spine Biologics Production (K Units) and Global Market Share of Orthofix International 2011-2016 93

Table Globus Medical Company Profile 94

Figure Spine Biologics Product Picture of Globus Medical 95

Table Spine Biologics Capacity (K Units), Production (K Units), Price (USDUnit), Cost (USDUnit), Gross (USDUnit), Revenue (M USD) and Gross Margin of Globus Medical 2011-2016 95

Figure Spine Biologics Capacity (K Units), Production (K Units) and Growth Rate of Globus Medical 2011-2016 96

Figure Spine Biologics Production (K Units) and Global Market Share of Globus Medical 2011-2016 96

Table Alphatec spine Company Profile 97

Figure Spine Biologics Product Picture of Alphatec spine 98

Table Spine Biologics Capacity (K Units), Production (K Units), Price (USDUnit), Cost (USDUnit), Gross (USDUnit), Revenue (M USD) and Gross Margin of Alphatec spine 2011-2016 98

Figure Spine Biologics Capacity (K Units), Production (K Units) and Growth Rate of Alphatec spine 2011-2016 99

Figure Spine Biologics Production (K Units) and Global Market Share of Alphatec spine 2011-2016 99

Table K2M Company Profile 100

Figure Spine Biologics Product Picture of K2M 101

Table Spine Biologics Capacity (K Units), Production (K Units), Price (USDUnit), Cost (USDUnit), Gross (USDUnit), Revenue (M USD) and Gross Margin of K2M 2011-2016 101

Figure Spine Biologics Capacity (K Units), Production (K Units) and Growth Rate of K2M 2011-2016 102

Figure Spine Biologics Production (K Units) and Global Market Share of K2M 2011-2016 102

Table Exactech Company Profile 103

Figure Spine Biologics Product Picture of Exactech 104

Table Spine Biologics Capacity (K Units), Production (K Units), Price (USDUnit), Cost (USDUnit), Gross (USDUnit), Revenue (M USD) and Gross Margin of Exactech 2011-2016 104

Figure Spine Biologics Capacity (K Units), Production (K Units) and Growth Rate of Exactech 2011-2016 105

Figure Spine Biologics Production (K Units) and Global Market Share of Exactech 2011-2016 105

Table Wright Medical Technology Company Profile 106

Figure Spine Biologics Product Picture of Wright Medical Technology 107

Table Spine Biologics Capacity (K Units), Production (K Units), Price (USDUnit), Cost (USDUnit), Gross (USDUnit), Revenue (M USD) and Gross Margin of Wright Medical Technology 2011-2016 107

Figure Spine Biologics Capacity (K Units), Production (K Units) and Growth Rate of Wright Medical Technology 2011-2016 108

Figure Spine Biologics Production (K Units) and Global Market Share of Wright Medical Technology 2011-2016 108

Table X-Spine Systems Company Profile 109

Figure Spine Biologics Product Picture of X-Spine Systems 110

Table Spine Biologics Capacity (K Units), Production (K Units), Price (USDUnit), Cost (USDUnit), Gross (USDUnit), Revenue (M USD) and Gross Margin of X-Spine Systems 2011-2016 110

Figure Spine Biologics Capacity (K Units), Production (K Units) and Growth Rate of X-Spine Systems 2011-2016 111

Figure Spine Biologics Production (K Units) and Global Market Share of X-Spine Systems 2011-2016 111

Table Nutech Company Profile 112

Figure Spine Biologics Product Picture of Nutech 113

Table Spine Biologics Capacity (K Units), Production (K Units), Price (USDUnit), Cost (USDUnit), Gross (USDUnit), Revenue (M USD) and Gross Margin of Nutech 2011-2016 113

Figure Spine Biologics Capacity (K Units), Production (K Units) and Growth Rate of Nutech 2011-2016 114

Figure Spine Biologics Production (K Units) and Global Market Share of Nutech 2011-2016 114

Table Arthrex Company Profile 115

Figure Spine Biologics Product Picture of Arthrex 116

Table Spine Biologics Capacity (K Units), Production (K Units), Price (USDUnit), Cost (USDUnit), Gross (USDUnit), Revenue (M USD) and Gross Margin of Arthrex 2011-2016 116

Figure Spine Biologics Capacity (K Units), Production (K Units) and Growth Rate of Arthrex 2011-2016 117

Figure Spine Biologics Production (K Units) and Global Market Share of Arthrex 2011-2016 117

Figure Marketing Channels of Spine Biologics 118

Table Traders or Distributors with Contact Information of Spine Biologics 119

Figure Ex-work Price, Channel Price and End Buyer Price of Spine Biologics (USDUnit) in 2015 120

Table Regional Import, Export, and Trade of Spine Biologics (K Units) 120

Table Global Capacity (K Units) of Spine Biologics by Regions 2016-2021 122

Figure Global Capacity Market Share of Spine Biologics by Regions in 2016 122

Figure Global Capacity Market Share of Spine Biologics by Regions in 2021 123

Table Global Production (K Units) of Spine Biologics by Regions 2016-2021 123

Figure Global Production Market Share of Spine Biologics by Regions in 2016 123

Figure Global Production Market Share of Spine Biologics by Regions in 2021 124

Table Global Revenue (M USD) of Spine Biologics by Regions 2016-2021 124

Figure Global Revenue Market Share of Spine Biologics by Regions in 2016 124

Figure Global Revenue Market Share of Spine Biologics by Regions in 2021 125

Figure Global Capacity (K Units), Production (K Units) and Growth Rate of Spine Biologics 2016-2021 125

Figure Global Capacity Utilization Rate of Spine Biologics 2016-2021 125

Figure Global Revenue (M USD) and Growth Rate of Spine Biologics 2016-2021 125

Figure North America Capacity (K Units), Production (K Units) and Growth Rate of Spine Biologics 2016-2021 126

Figure North America Capacity Utilization Rate of Spine Biologics 2016-2021 126

Figure North America Revenue (M USD) and Growth Rate of Spine Biologics 2016-2021 127

Figure Europe Capacity (K Units), Production (K Units) and Growth Rate of Spine Biologics 2016-2021 127

Figure Europe Capacity Utilization Rate of Spine Biologics 2016-2021 128

Figure Europe Revenue (M USD) and Growth Rate of Spine Biologics 2016-2021 128

Figure Asia Capacity (K Units), Production (K Units) and Growth Rate of Spine Biologics 2016-2021 129

Figure Asia Capacity Utilization Rate of Spine Biologics 2016-2021 129

Figure Asia Revenue (M USD) and Growth Rate of Spine Biologics 2016-2021 130

Table Global Production (K Units) of Spine Biologics by Types 2016-2021 130

Figure Global Production Market Share of Spine Biologics by Types in 2016 131

Figure Global Production Market Share of Spine Biologics by Types in 2021 131

Table Global Revenue (M USD) of Spine Biologics by Types 2016-2021 132

Figure Global Revenue Market Share of Spine Biologics by Types in 2016 132

Figure Global Revenue Market Share of Spine Biologics by Types in 2021 133

Table Global Consumption Volume (K Units) of Spine Biologics by Regions 2016-2021 133

Figure Global Consumption Volume Market Share of Spine Biologics by Regions in 2016 134

Figure Global Consumption Volume Market Share of Spine Biologics by Regions in 2021 134

Table Global Consumption Value (M USD) of Spine Biologics by Regions 2016-2021 135

Figure Global Consumption Value Market Share of Spine Biologics by Regions in 2016 135

Figure Global Consumption Value Market Share of Spine Biologics by Regions in 2021 136

Figure Global Consumption Volume (K Units) and Growth Rate of Spine Biologics 2016-2021 136

Figure Global Consumption Value (M USD) and Growth Rate of Spine Biologics 2016-2021 137

Figure North America Consumption Volume (K Units) and Growth Rate of Spine Biologics 2016-2021 137

Figure North America Consumption Value (M USD) and Growth Rate of Spine Biologics 2016-2021 138

Figure Europe Consumption Volume (K Units) and Growth Rate of Spine Biologics 2016-2021 138

Figure Europe Consumption Value (M USD) and Growth Rate of Spine Biologics 2016-2021 139

Figure China Consumption Volume (K Units) and Growth Rate of Spine Biologics 2016-2021 139

Figure China Consumption Value (M USD) and Growth Rate of Spine Biologics 2016-2021 140

Figure Asia (Ex. China) Consumption Volume (K Units) and Growth Rate of Spine Biologics 2016-2021 140

Figure Asia (Ex. China) Consumption Value (M USD) and Growth Rate of Spine Biologics 2016-2021 141

Table Global Consumption Volume (K Units) of Spine Biologics by Types 2016-2021 141

Figure Global Consumption Volume Market Share of Spine Biologics by Types in 2016 142

Figure Global Consumption Volume Market Share of Spine Biologics by Types in 2021 142

Table Global Consumption Value (M USD) of Spine Biologics by Types 2016-2021 143

Figure Global Consumption Value Market Share of Spine Biologics by Types in 2016 143

Figure Global Consumption Value Market Share of Spine Biologics by Types in 2021 144

Table Global Consumption Volume (K Units) of Spine Biologics by Applications 2016-2021 144

Figure Global Consumption Volume Market Share of Spine Biologics by Applications in 2016 145

Figure Global Consumption Volume Market Share of Spine Biologics by Applications in 2021 145

Table Global Consumption Value (M USD) of Spine Biologics by Applications 2016-2021 146

Figure Global Consumption Value Market Share of Spine Biologics by Applications in 2016 146

Figure Global Consumption Value Market Share of Spine Biologics by Applications in 2021 147

Table Global Supply, Consumption and Gap of Spine Biologics 2016-2021 (K Units) 147

Table North America Supply, Consumption and Gap of Spine Biologics 2016-2021 (K Units) 148

Table Europe Supply, Consumption and Gap of Spine Biologics 2016-2021 (K Units) 148

Table Asia Supply, Consumption and Gap of Spine Biologics 2016-2021 (K Units) 148

Table Global Capacity (K Units), Production (K Units), Price (USDUnit), Cost (USDUnit), Revenue (M USD) and Gross Margin of Spine Biologics 2016-2021 148

Table North America Capacity (K Units), Production (K Units), Price (USDUnit), Cost (USDUnit), Revenue (M USD) and Gross Margin of Spine Biologics 2016-2021 149

Table Europe Capacity (K Units), Production (K Units), Price (USDUnit), Cost (USDUnit), Revenue (M USD) and Gross Margin of Spine Biologics 2016-2021 149

Table Asia Capacity (K Units), Production (K Units), Price (USDUnit), Cost (USDUnit), Revenue (M USD) and Gross Margin of Spine Biologics 2016-2021 150

Table New Project SWOT Analysis of Spine Biologics 151

Table Project Appraisal and Financing 152

Table New Project Investment Feasibility Analysis of Spine Biologics 152